Cargando…
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
The development of chronic kidney disease (CKD) in people with diabetes is commonplace, and is frequently associated with a significant and unfavourable impact on patient outcomes along with a substantial economic burden. With the development of novel classes of drug therapies in diabetes, there has...
Autores principales: | Williams, David M., Nawaz, Asif, Evans, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995804/ https://www.ncbi.nlm.nih.gov/pubmed/31863343 http://dx.doi.org/10.1007/s13300-019-00747-3 |
Ejemplares similares
-
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials
por: Williams, David M., et al.
Publicado: (2020) -
Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy
por: Shimizu, Miho, et al.
Publicado: (2019) -
Impact of sodium-glucose co-transporter 2 inhibitors on renal outcomes in patients of diabetes mellitus: A meta-analysis of landmark renal and cardiovascular outcome trials
por: Bose, Debdipta, et al.
Publicado: (2023) -
Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
por: Lim, Jayoung, et al.
Publicado: (2022) -
Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
por: Hinnen, Deborah, et al.
Publicado: (2019)